Shanghai Fosun Pharmaceutical (Group) Co. Ltd. held shareholder meetings
I'm PortAI, I can summarize articles.
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. held its first extraordinary general meeting and class meetings for A and H shareholders on February 27, 2026. Shareholders approved the spin-off of Fosun Adgenvax for an IPO on the Hong Kong Stock Exchange, including plans for independence and operational capability. The proposal for assured entitlements to H shareholders was approved at the H meeting but not at the A meeting. This news is generated by AI and should not be considered financial advice.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: PUBT The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments